Trends on medicine use in county public hospitals in Sanming, China from 2011 to 2017.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 3, p. 218, doi. 10.5246/jcps.2022.03.020
- By:
- Publication type:
- Article
Works matching IS 10031057 AND DT 2022 AND VI 31 AND IP 3
Results: 7
1
2
The effects of the National Drug Pooled Procurement (NDPP) pilot program in China.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 3, p. 212, doi. 10.5246/jcps.2022.03.019
- By:
- Publication type:
- Article
3
Sildenafil improves endometrial blood flow in patients with recurrent implantation failure.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 3, p. 202, doi. 10.5246/jcps.2022.03.018
- By:
- Publication type:
- Article
4
Three previously undescribed steroidal glycoalkaloids from Solanum lyratum and their anti-tumor activities.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 3, p. 192, doi. 10.5246/jcps.2022.03.017
- By:
- Publication type:
- Article
5
Research on accurate quantitation technique using liquid chromatography coupled with triple quadrupole mass spectrometry and experiment optimization--take a novel diuretic as an example.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 3, p. 184, doi. 10.5246/jcps.2022.03.016
- By:
- Publication type:
- Article
6
A pharmacological study of pioglitazone in the regulation of adipocyte differentiation.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 3, p. 176, doi. 10.5246/jcps.2022.03.015
- By:
- Publication type:
- Article
7
Upper limb arthromyodynia can be treated with Notopterygium by down-regulating P2X3 to mediate PKC-induced inflammatory response.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 3, p. 163, doi. 10.5246/jcps.2022.03.014
- By:
- Publication type:
- Article